INmune Bio (NASDAQ:INMB – Get Rating) is scheduled to be posting its quarterly earnings results after the market closes on Wednesday, May 3rd. Parties that are interested in participating in the company’s conference call can do so using this link. INmune Bio (NASDAQ:INMB – Get Rating) last released its quarterly earnings data on Thursday, March […]
INmune Bio, Inc. (NASDAQ:NASDAQ:INMB) Q3 2022 Results Conference Call November 02, 2022 04:30 PM ET Company Participants David Moss - Chief Financial Officer Dr.
INmune Bio, Inc Announces Positive Solid Tumor Efficacy Data in Multiple Cancer Cell Lines for INKmune streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Equities analysts expect INmune Bio, Inc. (NASDAQ:INMB – Get Rating) to report earnings of ($0.60) per share for the current quarter, Zacks Investment Research reports. Zero analysts have made estimates for INmune Bio’s earnings. INmune Bio reported earnings of ($0.32) per share during the same quarter last year, which would indicate a negative year over […]